Advertisement

Topics

PharmaMar announces data presentations: Yondelis® and lurbinectedin at ASCO

20:00 EDT 16 May 2018 | AAAS

(Pharmamar) During the Congress of the American Society of Clinical Oncology (ASCO) that will be held form the June 1-5 in Chicago (USA), PharmaMar will present the data obtained from various clinical studies of the molecules Yondelis ®, lurbinectedin (PM1183) and plitidepsin.

Original Article: PharmaMar announces data presentations: Yondelis® and lurbinectedin at ASCO

NEXT ARTICLE

More From BioPortfolio on "PharmaMar announces data presentations: Yondelis® and lurbinectedin at ASCO"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topic

Cancer
  Bladder Cancer Brain Cancer Breast Cancer Cancer Cervical Cancer Colorectal Head & Neck Cancers Hodgkin Lymphoma Leukemia Lung Cancer Melanoma Myeloma Ovarian Cancer Pancreatic Cancer ...